Technical Analysis for VOQP - Vioquest Pharmaceutl

Grade Last Price % Change Price Change
grade F 0.002 0.00% 0.0000
VOQP closed unchanged on Monday, July 6, 2020, on 26 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical VOQP trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Older signals for VOQP ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases. Its lead product includes Xyfid, which is under development for the treatment and prevention of hand-foot syndrome. The company's products also consist of VQD-002, a nucleoside analog that is in Phase I clinical trials for the treatment of cancer; and Lenocta, a small molecule inhibitor of various protein tyrosine phosphatases, which is in Phase IIa clinical trials for the treatment of melanoma, renal cell carcinoma, and other solid tumors. VioQuest Pharmaceuticals also provides chiral products, technology, and custom synthesis development services to pharmaceutical and fine chemical companies in various stages of a products' lifecycle. The company was founded in 2000 and is headquartered in Basking Ridge, New Jersey.
Medicine Cancer Clinical Medicine Biopharmaceutical Chemical Infectious Diseases Treatment Of Cancer Solid Tumors Cancer Treatments Melanoma Targeted Therapy Drug Therapies Merck Renal Cell Carcinoma Cyclacel

Is VOQP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.265
52 Week Low 0.0004
Average Volume 20,795
200-Day Moving Average 0.0000
50-Day Moving Average 0.0079
20-Day Moving Average 0.0049
10-Day Moving Average 0.0040
Average True Range 0.0031
ADX 28.57
+DI 58.4906
-DI 35.3774
Chandelier Exit (Long, 3 ATRs ) -0.0001
Chandelier Exit (Short, 3 ATRs ) 0.0097
Upper Bollinger Band 0.0092
Lower Bollinger Band 0.0006
Percent B (%b) 0.16
BandWidth 175.5102
MACD Line -0.0020
MACD Signal Line -0.0018
MACD Histogram -0.0003
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0128
Resistance 3 (R3) 0.0140 0.0116 0.0110
Resistance 2 (R2) 0.0116 0.0088 0.0110 0.0104
Resistance 1 (R1) 0.0068 0.0072 0.0056 0.0056 0.0098
Pivot Point 0.0044 0.0044 0.0038 0.0038 0.0044
Support 1 (S1) -0.0004 0.0016 -0.0016 -0.0016 -0.0058
Support 2 (S2) -0.0028 0.0000 -0.0034 -0.0064
Support 3 (S3) -0.0076 -0.0028 -0.0070
Support 4 (S4) -0.0088